Varivax Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Live attenuated varicella virus (Oka/Merck strain)

Indications/Uses

Vaccination against varicella in individuals ≥12 mth.

Click to view Varivax detailed prescribing information

Dosage/Direction for Use

Adult & adolescent ≥13 yr Two 0.5-mL SC inj 4-8 wk apart. Childn 12 mth-12 yr 0.5-mL SC inj as single dose. Min interval of 3 mth between doses if 2nd dose is administered.

Click to view Varivax detailed prescribing information

Overdosage

View Varivax overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity to vaccine including gelatin; neomycin. Blood dyscrasias, leukemia, lymphoma or other malignant neoplasms affecting bone marrow or lymphatic system. Immunosuppressive therapy eg, high-dose corticosteroids. Primary & acquired immunodeficiency states. Family history of congenital or hereditary immunodeficiency. Active untreated TB; active febrile resp illness w/ fever >38.5°C. Avoid pregnancy for 3 mth following vaccination.

Click to view Varivax detailed prescribing information

Special Precautions

Not to be inj IV. HIV-infected w/ or w/o immunosuppression. Avoid close association w/ high-risk individuals eg, immunocompromised, pregnant women & newborn infants w/o documented +ve history of varicella or lab evidence of prior infection for up to 6 wk following vaccination. Avoid pregnancy for 3 mth after vaccination in women of childbearing potential. Not to be used during pregnancy. Lactation. Childn <1 yr. Not recommended in infant <12 mth.

Click to view Varivax detailed prescribing information

Use In Pregnancy & Lactation

Click to view Varivax detailed prescribing information

Adverse Reactions

Upper & lower resp illness, cough, irritability/nervousness, fatigue, disturbed sleep, diarrhea, loss of appetite, vomiting, otitis, headache, teething, malaise, abdominal pain, other rash, nausea, eye complaints, chills, lymphadenopathy, myalgia, allergic reactions (including allergic rash & hives), stiff neck, arthralgia, itching.

Drug Interactions

Reye syndrome w/ salicylates; avoid use 6 wk after vaccination. Defer vaccination at least 5 mth following Ig or varicella-zoster Ig administration, or blood or plasma transfusions.

Click to view Varivax detailed prescribing information

Storage

View Varivax storage conditions for details to ensure optimal shelf-life.

Description

View Varivax description for details of the chemical structure and excipients (inactive components).

Action

View Varivax mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BK01 - varicella, live attenuated ; Belongs to the class of varicella viral vaccines.

Regulatory Classification

Presentation/Packing

Form

Varivax vaccine (inj) (lyo, vial) 0.5 mL

Packing/Price

(+ diluent) 1's

Varivax

vaccine, varicella-zoster

Manufacturer:

Merck Sharp & Dohme

Distributor:

Zuellig Pharma